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Abstract
In the present work we set out to investigate the neuroprotective effects of noscapine (0.5-
2 µM) in presence of D-glucose on primary murine foetal cortical neurons after oxygen–
glucose deprivation/24 h. recovery. Cell viability, nitric oxide production and intracellular 
calcium ((ca2+)i) levels were evaluated by MTT assay, the modified Griess method and Fura-2 
respectively. 25 and 100 mM D-glucose could, in a concentration dependent manner, improve 
cell viability and decrease NO production and (ca2+)i level in neuronal cells after ischemic 
insult. Moreover, pre-incubation of cells with noscapine, noticeably enhanced protective 
effects of 25 and 100 mM D-glucose compared to similar conditions without noscapine pre-
treatment. In fact, noscapine attenuated NO production in a dose-dependent fashion, after 30 
minutes (min) OGD, during high-glucose (HG) condition in cortical neurons. Pretreatment 
with 2 μM noscapine and 25 or 100 mM D-glucose, was shown to decrease the rise in (ca2+)i 
induced by Sodium azide/glucose deprivation (chemical OGD) model. These effects were more 
pronounced than that of 25 or 100 mM D-glucose alone.
The present study demonstrated that the neuroprotective effects of HG before an ischemic 
insult were augmented by pre-treatment with noscapine. Our results also suggested that the 
neuroprotection offered by both HG and noscapine involve attenuation of NO production and 
(ca2+)i levels stimulated by the experimental ischemia in cortical neurons.
Keywords: Noscapine; D-glucose; intracellular calcium levels; NO; Oxygen-Glucose 
Deprivation.
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Introduction
Diabetes mellitus is a common metabolic 
disease characterized by hyperglycemia which 
often leads to nerve injury probably through the 
induction of systemic and neuronal oxidative 
stress (1, 2). It has been shown that high glucose 
(HG) induces oxidative stress and cell death 
via NADPH oxidase dependent generation of 
reactive oxygen species and NO production 
(3, 4).
During cerebrovascular accidents, ischemia 
induced metabolic deficiency appears to 
promote a cascade of events leading to neuronal 
cell death via both necrosis and apoptosis (5-7). 
In other words, ischemia induced glucose and/
or oxygen deficiencies can cause both cellular 
and functional damage to the brain (8, 9). Also, 
neuronal cells deprived of means of production 
of energy appear to be highly susceptible to 
excitotoxicity (8, 10-13). Although glucose 
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appears to be essential in normal function of 
the nervous system (14), there is conflicting 
evidence regarding the effects of extracellular 
glucose concentration on various forms of 
ischemic injury (9). Some studies have found 
that hyperglycemia worsens the effects of 
ischemic insult, probably due to enhanced lactate 
generation which results in tissue acidosis and 
leads to generation of reactive oxygen species 
(9, 15-23). In contrast, other studies have found 
that elevated glucose levels before hypoxic insult 
reduced neuronal damage (9, 24-28), while other 
studies have demonstrated that hyperglycemia 
can decrease glutamate levels released during 
ischemia (9, 15, 29-31). Corroborating evidence 
of neuroprotective effects of glucose was 
provided by Dave KR, Pileggi A and Raval AP 
(32) who showed that exposure of hippocampal 
slices to hypoglycemia prior to ischemic insult 
exacerbated ischemia induced damage.
Research on noscapine, a non-addictive 
antitussive alkaloid of opium, as a neuroprotective 
agent in our laboratory had previously shown it 
efficacy in attenuating brain injury after hypoxia 
in neonatal rats (33). Also, in a limited clinical 
trial, it was shown that noscapine reduced 
sharply the mortality rate of stroke patients (34).
In order to delineate the mechanism of the 
neuroprotective effects of noscapine, in this 
study, we investigated if noscapine could protect 
primary murine fetal cortical neurons exposed 
to oxygen-glucose deprivation/24 h. recovery 
during high glucose condition. The intracellular 
free calcium concentration and NO production 
were measured as two important factors during 
ischemic insult.
Experimental
Chemicals and reagents
Noscapine was obtained from Temad-D 
Pharmaco-Chemical Company (Tehran, Iran). 
The stock solution was prepared at 1 mol/L in 
dimethyl sulfoxide (DMSO) and stored at –20 °C. 
RPMI-1640, glutamine-free Dulbecco’s Modified 
Eagle’s Medium (DMEM), foetal bovine serum 
(FBS), horse serum, penicillin- streptomycin, 
cytosine arabinoside, 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyl-tetrazolium bromide (MTT), 
D-glucose, fura-2 AM, poly-L-lysine, NG nitro-
L-arginine methyl ester (L-NAME), Mannitol, 
sodium-azide (NaN3) and modified Griess 
reagent were purchased from Sigma Chemical 
Co. (St. Louis, MO, USA). All other chemicals 
used were of the purest grade available from 
regular commercial sources.
Murine Neuronal Cell Cultures
Primary cultures of cerebral cortex neurons 
were obtained from mouse embryos (E15–18) 
as described previously (35, 36). Briefly, 
timed-pregnant mice were anaesthetised with 
chloroform and killed by cervical dislocation. 
Foetuses were removed and decapitated with 
small scissors. Skull cap were removed, cerebral 
cortex was isolated and the cortex was cut into 
small pieces. The tissue was then dissociated by 
repeated pipetting. The resulting homogenate 
was centrifuged at 300×g and 20 °C for 5 min and 
plated on poly-L-lysine-coated 12-well culture 
dishes at a density of 6×104 cells in RPMI-1640 
medium supplemented with 10% FBS, 5% horse 
serum, 100 IU/mL penicillin and 100 µg/ mL 
streptomycin. Poly-L-lysine (150,000–300,000 
MW) was dissolved in deionised water, and the 
plate bases were filled with this solution (20 µg/ 
mL) 24 h. before the experiment. After 5 min 
standing at room temperature, the solution was 
aspirated, and the plates were left to dry in a 
laminar flow bench overnight. The culture dishes 
were kept at 37 °C in humidified 95% air and 5% 
CO2. After 24–48 h. 10 µM cytosine arabinoside 
(cytosine 1-β-D-arabinofuranoside) was added 
to the culture medium to inhibit the proliferation 
of non-neuronal cells. The culture medium was 
changed twice weekly, and the neurons were used 
for experiments after 13–16 days of incubation. 
All experiments were approved by the Institute 
of Animal Care Committee at the Iran University 
of Medical Sciences.
Oxygen–glucose deprivation and drug 
exposure
Procedures for oxygen–glucose deprivation 
(OGD) were performed as described previously 
(37). Neuronal cells were incubated for 24 h. in 
RPMI-1640 containing 25, 100 mM D-glucose 
in presence or absence of noscapine. The culture 
medium was replaced with glucose/glutamine-
free DMEM, and cells were exposed to OGD for 
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30 min in a small anaerobic chamber previously 
filled with 95 % (v/v) N2 and 5 % (v/v) CO2 at 37 
°C. To terminate OGD, the chamber was opened, 
the medium was replaced with RPMI-1640 and 
the cultures were then placed in an incubator 
with 5 % CO2 for 24 h. To examine the effects 
of noscapine, the drug (0.5-2 µM) was added to 
cultures in media containing 25 mM or 100 mM 
D-glucose 24 h. before OGD. The concentrations 
of noscapine were chosen based on the results 
of preliminary experiments to identify nontoxic 
levels (data not shown). All measurements were 
repeated at least three times. 
Analysis of neuronal cell viability
Neuronal cell viability was measured using 
the colorimetric MTT assay, as previously 
described by Mosmann T (38). Briefly, cells 
were incubated with 0.5mg/mL MTT in RPMI at 
37 ºC under 5 % CO2 for 3 h. The blue formazan 
reduction product, which is generated by the 
action of the succinate dehydrogenase on the 
dye only in living cells, was dissolved in 100µL 
DMSO, and its absorbance was read at 570nm 
using a Dynex MMX microplate reader (Dynex, 
Richfield, MN, USA). The data were expressed 
as the percentage of viable cells in oxygen–
glucose deprivation-exposed plates compared 
with control normoxic plates.
Measurement of nitrite levels
The level of nitrite as an indicator of NO 
production in the culture medium was measured 
using modified Griess reagent. In brief, after 
the experiment, the medium in each well was 
removed and centrifuged at 10,000 g for 10 min 
at 20 ºC. Then, 100 µL of the supernatant was 
mixed with an equal volume of Griess reagent at 
room temperature for 10 min, and the absorbance 
was measured at 540 nm using a microplate 
reader. The nitrite concentration was determined 
from a sodium nitrite standard curve. Plates not 
exposed to OGD were used as external control, 
and plates exposed to OGD without the addition 
of any drug were used as an internal control.
Measurement of intracellular free calcium
Measurement of intracellular free calcium 
concentration was performed using the Ca2+-
sensitive indicator fura-2 bya Olympus IX-71 
inverted microscope and CCD camera equipped 
with an automated filter changer. Cortical cell 
cultures grown on a coverslips were loaded 
with 4 µM fura-2/AM at room temperature for 
30 min. Cells were washed three times with a 
salt solution containing (in mM): 140 NaCl, 3 
KCl, 2.5 CaCl2, 1.2 MgCl2, 7.7 glucose and 10 
HEPES, pH 7.4. The fura-2 fluorescent images 
(Ex 340/380 nm; Em 510 nm) were acquired. 
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Figure 1. Effects of normal and high glucose on cell viability for 24 h. Primary cultured 
murine cortical neurons incubated in low glucose (4.5 mM), high glucose (25 and 100 mM), or 
mannitol (100 mM) containing medium.  Mannitol (100 mM) was used as an osmotic control for 
the high-glucose concentration. Bar graph indicates the mean ± S.E.M.* P< 0.001, vs. normal 
glucose control. 
 
 
Exposure to 30 min of OGD decreased viability of neuronal cells which had been kept in 
media with normal glucose to 55.58±1.09. Neuronal cells pretreated for 24 h. with 25 or 100 mM 
glucose prior to OGD exposure showed an increase in cell viability (71.47±0.79 and 80.56±0.66 
respectively) when compared with normal glucose medium (Figure 2a-b). 
 
Figure 2(A) 
Figure 1. Effects of normal and high glucose on cell viability for 24 h. Primary cultured murine cortical neurons incubated in low glucose 
(4.5 mM), high glucose (25 and 100 mM), or mannitol (100 mM) containing medium.  Mannitol (100 mM) was used as an osmotic 
control for the high-glucose concentration. Bar graph indicates the mean ± S.E.M.* P< 0.001, vs. normal glucose control.
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Ratio metric analyses were carried out using 
Image J software (NIH).
Statistical analysis 
All results are expressed as the means ± 
S.E.M. The significance of differences was 
evaluated with student’s t-test. A probability 
level of P<0.05 was considered statistically 
significant.
Results
The effects of noscapine in high glucose 
conditions on primary cortical neurons exposed 
to 30 minutes OGD 
We examined the effect of D-glucose in 
cell viability as measured by the MTT assay. 
Our results demonstrated that after 24 h. of 
exposure to 25 or 100 mM D-glucose neuronal 
cell viability was reduced by 73.5±1.04 and 
53.15±0.47 respectively. As shown in Figure 
1 the decrease in cell viability induced by 
HG media was concentration dependent and 
statistically significant when compared to the 
control cultures which were incubated in media 
with normal glucose concentration (4.5mM). 
We explored the effects of high osmolarity on 
neuronal cell death by pre-treating neuronal 
culture with 100 mM mannitol (negative control 
for osmolarity). Our results indicated that there 
was no significant difference in cell viability 
between neuronal cultures in control group (100 
%) versus 100 mM mannitol (98.67±0.1). Thus 
any observed change in cell viability is due, 
directly, to the effect of glucose on neuronal 
cells.
Exposure to 30 min of OGD decreased 
viability of neuronal cells which had been kept 
in media with normal glucose to 55.58±1.09. 
Neuronal cells pretreated for 24 h. with 25 or 
100 mM glucose prior to OGD exposure showed 
an increase in cell viability (71.47±0.79 and 
80.56±0.66 respectively) when compared with 
normal glucose medium (Figure 2a-b).
In order to determine if noscapine (0.5-2 
µM) could affect neuronal cells viability in the 
presence of 25 and 100 mM D-glucose prior 
to 30 min OGD, cultures were pretreated with 
noscapine and HG. Our results showed that in 
the presence of noscapine protective effect of 
glucose was potentiated significantly compared 
to that of D-glucose alone (Figure2a-b). The 
increase in cell viability was 95.67±1.02 and 
98.91±0.66 for 2 µM noscapine, the most 
effective concentration, in the presence of 25 
and 100 mM D-glucose.
The effects of noscapine in high glucose 
conditions on NO production in primary cortical 
neurons exposed to 30 minutes OGD 
 We examined the effects of noscapine in 
HG conditions on NO production in primary 
cortical neurons exposed to 30 min OGD. As 
shown in Figure. 3a-b, under normal glycemic 
pre-treatment, neuronal cells exposed to 30 
min OGD, produced significantly more nitrite 
compared to groups which were not exposed to 
OGD (P<0.001). Cortical neurons pre-treated 
with 25 or 100 mM D-glucose prior to exposure 
to 30 min OGD produced significantly less NO 
1.42±0.09 µM and 1.27±0.08 µM respectively. 
Pre-treating neurons with noscapine (0.5-2µM) 
during HG condition (25 or 100 mM) induced a 
further decrease in NO production as compared 
with HG alone (P<0.001). The neuronal NO 
production induced by 30 min of OGD was 
attenuated by 100 µM L-NAME, a nitric oxide 
synthase inhibitor (Figure 3a-b).
The effects of noscapine in high glucose 
conditions on intracellular calcium levels 
against chemical OGD 
To determine the intracellular calcium levels 
during ischemia, the neuronal cells were exposed 
to 30 min sodium-azide (4 mM) as a model of 
chemical OGD in the absence of glucose. 4 mM 
NaN3 was able to induce a significant increase in 
(Ca2+)i levels in cortical neurons bathed in Ca
2+-
containing medium (169.87±4.73) (Figure.4-5). 
Exposure of cortical neurons to sodium azide 
and 25 mM or 100 mM D-glucose after 30 min 
of OGD, decreased (Ca2+)i levels by 161.23±4.29 
and 143.33±2.23 respectively. Furthermore, the 
ischemia-evoked increase in (Ca2+)i levels was 
decreased by 150.82±2.7 and 124.12±1.87 in the 
presence of 2 µM noscapine with 25 or 100 mM 
D-glucose respectively (Figure 4-5).
Discussion
Hyperglycemia appears to be an important 
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factor in the development of diabetic neuropathy 
(2). It induces neuronal damage and dysfunction 
probably via the generation of reactive oxygen 
species (2, 39). As such, many studies have 
shown that HG does indeed cause neuronal 
cell death (2-4). However, there is conflicting 
Figure 2(A)
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Figure 2(B)
Figure 2. The effect of noscapine (Nos) in the presence of 25 mM (A) or 100 mM (B) D-glucose (Glu) on primary cultured murine 
cortical neurons subjected to a 30 min oxygen-glucose deprivation/24 h. recovery-induced cell injury. * P< 0.001 vs. internal control 
group (Normal Glu). External control: the plates not exposed to OGD and without addition any drugs.
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evidence regarding the role of extracellular 
glucose during brain ischemic insults (9). It is 
generally held that glucose supplies the essential 
energy needs of the brain and alteration of glucose 
metabolism may result in dysfunction of the 
CNS (8, 14). A number of studies have obtained 
evidence for the beneficial effects of enhanced 
glucose entry into neurons during ischemia (14, 
40, 41). These works suggest a protective role 
for glucose against excitotoxicity and hypoxic 
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Figure 3. The effect of noscapine (Nos) on NO production in the presence of 25 mM (A) or 100 mM (B) D-glucose (Glu) on murine 
primary cultured cortical neurons during a 30 min oxygen-glucose deprivation/24 h. recovery-induced cell injury. *P< 0.001 vs. internal 
control group (Normal Glu). The values are presented as the mean ± S.E.M. External control: the plates not exposed to OGD and without 
addition any drugs.
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ischemia. In the current study, we aimed to show 
the effects of HG on intracellular Ca2+ levels, 
NO production, and general cell viability in the 
absence and presence of noscapine which we 
had  previously shown to have neuroprotective 
effects of its own (42).
We examined the effect of D-glucose (25 or 
100 mM) on neuronal cell death. Cortical cultures 
were exposed, for 24 h. to 4.5 mM (as normal 
glucose control), 25 and 100 mM glucose (as 
high glucose). Our results showed that 25 and 100 
mM D-glucose could significantly reduce cell 
viability in a concentration dependent fashion 
as compared with control. In fact, neuronal 
cell viability treated with 100 mM glucose 
was markedly reduced as compared to 25 mM 
D-glucose. This was consistent with previous 
studies demonstrating that high concentrations 
of glucose induced neuronal injury in an in-
vitro model (2, 4, 43). For example, Koshimura 
K, Tanaka J, Murakami Y and Kato Y (4) 
showed that HG increased NO production and 
induced cell death in differentiated PC12 cells. 
Also, Vincent AM, McLean LL, Backus C 
and Feldman EL (43) demonstrated that in 
neurons, HG caused oxidative stress, induced 
mitochondrial dysfunction and programmed cell 
death. Thus, the data obtained by us and other 
workers, confirmed exposure to HG for 24 h. or 
more, to be detrimental to neuronal cells.
However, there is data to suggest a 
neuroprotective role for short period exposure to 
HG after ischemia (40). Here the mechanism of 
protection is not completely delineated. Toping 
up of intracellular glucose stores has been 
proposed to be the reason for this effect (9, 44). 
Thus, to determine whether a short exposure to 
HG could protect cortical neuronal cells from 
OGD insult, cells were pre-incubated for 24 h. 
in RPMI-1640 containing 25 or 100 mM glucose 
prior to 30 min OGD.  Exposure to HG reduced 
cell death due to OGD. This effect was more 
visible for 100 mM D-glucose than that of 25 
mM D-glucose.
Other workers have shown HG to be 
protective against the effects of excitotoxins 
(8, 9, 41). Seo SY, Kim EY, Kim H and Gwag 
BJ (8) showed that although pretreatment with 
25 mM glucose did not induce great protection 
against NMDA evoked neuronal death, 100 mM 
glucose pretreatment enhanced cell survival after 
treatment with NMDA. It has been demonstrated 
that OGD induces cell death by enhancing the 
release of extracellular glutamate which in 
turn increases activation of NMDA receptors 
leading to increased intracellular Ca2+ levels and 
augmented NO production (45-48). Thus the 
data obtained by us is in part agreement with the 
work of many other researchers (8, 9, 14, 40, 41).
All this suggests an important role for 
intracellular Ca2+ and NO in both excitotoxicity 
and OGD induced cell death. 
In a previous study carried out in this lab, 
effects of noscapine on OGD induced death 
in primary cortical neurons had been studied 
(42). Noscapine appeared to impart protection 
against ischemia by attenuating OGD induced 
NO production. In this study we investigated the 
possibility that noscapine could potentiate the 
protective effects of HG from OGD in primary 
cortical neurons. When neuronal cells pre-
treated with noscapine (0.5-2 µM)  subsequent 
the addition of HG ( 25 or 100 mM) and then 
subjected to 30 min OGD, the cell viability 
increased as compared with the cell pre-treated 
with high-glucose alone. In order to find out 
the neuroprotective effect of noscapine in HG 
condition, we set out to measure the change in 
Ca2+ and NO after OGD in cells pretreated with 
HG.
Sodium azide/glucose deprivation (chemical 
OGD) model was used to create in-vitro ischemic 
conditions. This model has been shown to elicit 
electrophysiological and neurochemical changes 
that are similar to the OGD model of ischemia. 
While this model having the advantage of 
producing neurochemical changes more rapidly 
and reproducibly (49, 50), thus facilitating the 
recording of changes in (Ca2+)i (51). Our results 
showed that during chemical OGD the (Ca2+)i 
was significantly increased compared to control 
condition. This is consistent with previous 
studies indicating that NaN3 could increase 
neuronal (Ca2+)i, as a consequence of energy 
depletion (52).
We next examined the (Ca2+)i level in 
neuronal cells exposed to 25 or 100 mM 
D-glucose after 30 min of chemical OGD 
treatment. The results suggested that exposure to 
25 or 100 mM D-glucose was able to reverse the 
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effects of chemical OGD on intracellular Ca2+ 
levels in cultured cortical neurons. Also, 100 
mM glucose was more effective in decreasing 
(Ca2+)i levels than 25 mM glucose. Chan J and 
Greenberg DA (53) showed that in PC12 cells, 
increasing glucose concentration in the culture 
medium by a factor of 4, attenuated ischemic 
injury by reducing the dihydropyridine-sensitive 
and depolarization-induced increase in Ca2+. 
These results suggested that HG might decrease 
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Figure 4. Changes in (Ca2+)i levels induced by chemical OGD (4 mM NaN3) in the presence and absence of 2 µM noscapine during 25 
mM D-glucose in primary cortical neurons. (A) Time course of NaN3-induced (Ca
2+)i rise in presence and absence of 2 µM noscapine 
during 25 mM D-glucose. NaN3 (4 mM) stimulated (Ca
2+)i levels increase. 25 mM D-glucose could decrease (Ca2+)i levels during 
chemical ischemia. 2 µM noscapine added to 25 mM D-glucose during ischemia reduced the (Ca2+)i levels than that of 25 mM D-glucose 
alone. (B) Bar graph of mean change in (Ca2+)i levels acquired in response to chemical ischemia in presence and absence of 2 µM 
noscapine during 25 mM D-glucose. Significant difference from control group (baseline) and chemical ischemic groups *p <0.001.
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neuronal cell death by reducing (Ca2+)i levels in 
neuronal cells. 
Finally, our findings demonstrated that 
cells exposed to D-glucose together with 
2 µM noscapine following chemical OGD 
had significantly lower (Ca2+)i compared to 
D-glucose treatment alone. This data suggests 
that noscapine reinforced the protective effect 
of HG via reduction in intracellular Ca2+ levels. 
Also, noscapine potentiated the effects of 100 
mM glucose more than it decreased the effects 
of 25 mM glucose. However, because 100 mM 
D-glucose could considerably reduce cell death 
during ischemic insult, the neuroprotective 
effect of 2 µM noscapine in presence of 100 mM 
D-glucose also could better act on neuronal cells 
to reduce (Ca2+)i following chemical OGD.
Many studies have been shown that NO is 
involved in both physiological and pathological 
events, and is believed to play different roles 
in both lethal and sub-lethal events (47, 54). 
Several studies have found evidence indicating 
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Figure 4. Changes in (Ca2+)i levels induced by chemical OGD (4 mM NaN3) in the presence 
and absence of 2 µM noscapine during 25 mM D-glucose in primary cortical neurons. (A) Time 
course of NaN3-induced (Ca2+)i rise in presence and absence of 2 µM noscapine during 25 mM 
D-glucose. NaN3 (4 mM) stimulated (Ca2+)i levels increase. 25 mM D-glucose could decrease 
(Ca2+)i levels during chemical ischemia. 2 µM noscapine added to 25 mM D-glucose during 
ischemia reduced the (Ca2+)i levels than that of 25 mM D-glucose alone. (B) Bar graph of mean 
change in (Ca2+)i levels acquired in response to chemical ischemia in presence and absence of 2 
µM noscapine during 25 mM D-glucose. Significant difference from control group (baseline) 
and chemical ischemic groups *p <0.001. 
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Figure 5(A)
Figure 5. Changes in (Ca2+)i levels induced by chemical OGD (4 mM NaN3) in the presence and absence of 2 µM noscapine during 100 
mM D-glucose in primary cortical neurons. (A) Time course of NaN3-induced (Ca
2+)i rise in presence and absence of 2 µM noscapine 
during 100 mM D-glucose. NaN3 (4 mM) stimulated (Ca
2+)i levels increase. 100 mM D-glucose could decrease (Ca2+)i levels during 
chemical ischemia. 2 µM noscapine added to 100 mM D-glucose during ischemia reduced the (Ca2+)i levels than that 0f 100 mM 
D-glucose alone. (B) Bar graph of mean change in (Ca2+)i levels acquired in response to chemical ischemia in presence and absence of 2 
µM noscapine during 100 mM D-glucose. Significant difference from control group (baseline) and chemical ischemic groups *p <0.001.
 Vahabzadeh G et al. / IJPR (2016), 15 (2):: 501-512
510
an involvement of NO synthase (NOS) in 
glutamate-induced excitotoxicity and there were 
some corroborating data that NO production 
increases during ischemia (35, 45, 47, 55-57). 
For example, it has been shown that during OGD, 
calcium enters the neurons through NMDA 
receptor and/or L-type voltage-gated calcium 
channel activation and activates NOS which 
leads to NO production (45). Zhang M, Ning 
G-M, Hong D-H, Yang Y, Kutor J and Zheng 
X-X (47) had shown that Ca2+-free medium 
markedly inhibited the OGD-induced increase in 
NO, suggesting that the inhibition of Ca2+ might 
cause the decrease of NO synthesis.
Our results confirmed that in neuronal cells 
exposed to 30 min OGD, NO production was 
significantly increased, supporting a role for 
NO in the cascade of events leading to OGD-
induced cell death (45). However, the exposure 
of neuronal cells to 25 or 100 mM D-glucose 
could decrease the NO production during 30 min 
OGD. After that neuronal cells were pre-treated 
with noscapine (0.5-2 µM) in the presence of 
the 25 or 100 mM D-glucose and then subjected 
to 30 min OGD. The results indicated that the 
NO production was significantly reduced as 
compared with 25 or 100 mM D-glucose alone. 
This suggested that noscapine also increased 
neuroprotective effect of HG by reducing NO 
production.  In addition, when the cultures were 
pre-treated with the NOS inhibitor, L-NAME, 
NO production was significantly decreased and 
returned to the level of the external control. 
Suggesting that NOS inhibitors could markedly 
decrease the NO production after NMDA 
receptor activation, and decreased excitotoxic 
injury in cultured neurons (45, 58, 59)
In conclusion, noscapine potentiated the 
neuroprotective effect of HG (25 and 100 mM) 
treatment prior to OGD. The enhanced cell 
viability after treatment with both noscapine 
and HG was mirrored by a dampening of OGD 
induced intracellular Ca2+ and NO rise. These 
observations support the hypothesis that calcium 
homeostasis and NO production have crucial 
roles in excitotoxicity process.
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